Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
- PMID: 11707567
- PMCID: PMC61120
- DOI: 10.1073/pnas.191502998
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
Abstract
We have generated a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Using oligonucleotide microarrays, we analyzed mRNA expression levels corresponding to 12,600 transcript sequences in 186 lung tumor samples, including 139 adenocarcinomas resected from the lung. Hierarchical and probabilistic clustering of expression data defined distinct subclasses of lung adenocarcinoma. Among these were tumors with high relative expression of neuroendocrine genes and of type II pneumocyte genes, respectively. Retrospective analysis revealed a less favorable outcome for the adenocarcinomas with neuroendocrine gene expression. The diagnostic potential of expression profiling is emphasized by its ability to discriminate primary lung adenocarcinomas from metastases of extra-pulmonary origin. These results suggest that integration of expression profile data with clinical parameters could aid in diagnosis of lung cancer patients.
Figures
Similar articles
-
Diversity of gene expression in adenocarcinoma of the lung.Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13784-9. doi: 10.1073/pnas.241500798. Epub 2001 Nov 13. Proc Natl Acad Sci U S A. 2001. PMID: 11707590 Free PMC article.
-
Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development.PLoS Med. 2006 Jul;3(7):e232. doi: 10.1371/journal.pmed.0030232. PLoS Med. 2006. PMID: 16800721 Free PMC article.
-
Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.J Pathol. 2006 Oct;210(2):192-204. doi: 10.1002/path.2039. J Pathol. 2006. PMID: 16915569
-
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.J Clin Oncol. 2006 Nov 1;24(31):5079-90. doi: 10.1200/JCO.2005.05.1748. J Clin Oncol. 2006. PMID: 17075127 Review.
-
[Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].Rinsho Byori. 1996 Jan;44(1):32-41. Rinsho Byori. 1996. PMID: 8691638 Review. Japanese.
Cited by
-
Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.Cancer Res. 2012 Aug 1;72(15):3725-34. doi: 10.1158/0008-5472.CAN-11-3943. Epub 2012 Jun 18. Cancer Res. 2012. PMID: 22710433 Free PMC article.
-
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.Cancer Discov. 2012 Sep;2(9):798-811. doi: 10.1158/2159-8290.CD-12-0112. Epub 2012 Sep 6. Cancer Discov. 2012. PMID: 22961666 Free PMC article.
-
Heat-shock factor 2 is a suppressor of prostate cancer invasion.Oncogene. 2016 Apr 7;35(14):1770-84. doi: 10.1038/onc.2015.241. Epub 2015 Jun 29. Oncogene. 2016. PMID: 26119944 Free PMC article.
-
TSG: a new algorithm for binary and multi-class cancer classification and informative genes selection.BMC Med Genomics. 2013;6 Suppl 1(Suppl 1):S3. doi: 10.1186/1755-8794-6-S1-S3. Epub 2013 Jan 23. BMC Med Genomics. 2013. PMID: 23445528 Free PMC article.
-
Recursive integration of synergised graph representations of multi-omics data for cancer subtypes identification.Sci Rep. 2022 Sep 17;12(1):15629. doi: 10.1038/s41598-022-17585-2. Sci Rep. 2022. PMID: 36115864 Free PMC article.
References
-
- Greenlee R T, Hill-Harmon M B, Murray T, Thun M. CA Cancer J Clin. 2001;51:15–36. - PubMed
-
- Druker B J, Talpaz M, Resta D J, Peng B, Buchdunger E, Ford J M, Lydon N B, Kantarjian H, Capdeville R, Ohno-Jones S, et al. N Engl J Med. 2001;344:1031–1037. - PubMed
-
- Travis W D, Travis L B, Devesa S S. Cancer. 1995;75:191–202. - PubMed
-
- Sorensen J B, Hirsch F R, Gazdar A, Olsen J E. Cancer. 1993;71:2971–2976. - PubMed
-
- Breathnach O S, Kwiatkowski D J, Finkelstein D M, Godleski J, Sugarbaker D J, Johnson B E, Mentzer S. J Thorac Cardiovasc Surg. 2001;121:42–47. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases